AzTrials
AzTrials

Mild Cognitive Impairment (MCI)Phase 2NCT01212692

Effects of Mental Stimulation in Patients With Mild Cognitive Impairment

A Phase 2 study testing mentally stimulating activities in people with Mild Cognitive Impairment (MCI), run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to learn if activities that challenge the brain (mentally stimulating activities) can improve memory and other types of thinking in patients with Mild Cognitive Impairment. The study will compare the effects of different methods of mental stimulation. Read more about this study

Who is it for?
Ages 50 to 100 years
Conditions the study is for
Mild Cognitive Impairment (MCI)
What is being tested?
mentally stimulating activities
Could I receive a placebo?
No, everyone receives an active treatment
How many people
63 participants
Where
1 siteUnited States
Study dates
Oct 2010to Jun 2014
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 50 years of age
  • meet criteria for amnestic-Mild Cognitive Impairment (MCI)
  • have capacity to give informed consent
  • have capacity to complete assessment measures

Who cannot join

  • history of drug or alcohol dependence
  • severe psychiatric conditions associated with psychosis (e.g., schizophrenia)
  • recent stroke
  • clinical diagnosis of probable Alzheimer's Disease
  • history of seizure disorder, serious head trauma, or other medical, psychiatric, or neurological conditions associated with significant cognitive impairment (e.g., Parkinson's Disease, Korsakoff's, HIV)
  • current use of Alzheimer's Disease medications (e.g., cholinesterase inhibitors, memantine)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • BPRU, Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, 21224

Other trials in United States

About this study

Official title: A Theoretically Based Memory Training Intervention in Mild Cognitive Impairment

The purpose of this study is to learn if activities that challenge the brain (mentally stimulating activities) can improve memory and other types of thinking in patients with Mild Cognitive Impairment. The study will compare the effects of different methods of mental stimulation.

Being tested
mentally stimulating activities
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mentally stimulating activitiesBehavioural

    The study will compare the effects of different methods of mental stimulation. The intervention involves 6 classroom-style educational sessions and 10 mental stimulation studies involving computerized memory tasks.

Study groups in NCT01212692
Study groupRoleWhat they receive
Mentally stimulating activitiesExperimentalNot described
Receives: Behavioral: mentally stimulating activities
Mentally stimulating activities- otherActive comparatorNot described
Receives: Behavioral: mentally stimulating activities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-Ordered Pointing Task

    Measured: baseline

  2. Trail-Making

    Measured: baseline

  3. Timed Instrumental Activities of Daily Living

    Measured: baseline

  4. Rey Auditory Verbal Learning Test

    Measured: baseline

  5. Self-ordered pointing task

    Measured: immediately after the intervention

  6. Self-ordered pointing task

    Measured: 3 months post intervention

  7. Self-ordered pointing task

    Measured: 9 months post-intervention

  8. Trail-Making

    Measured: immediately after the intervention

  9. Trail-Making

    Measured: 3 months post-intervention

  10. Trail-Making

    Measured: 9 months post-intervention

  11. Timed Instrumental Activities of Daily Living

    Measured: immediately after the intervention

  12. Timed Instrumental Activities of Daily Living

    Measured: 3 months post-intervention

  13. Timed Instrumental Activities of Daily Living

    Measured: 9 months post-intervention

  14. Rey Auditory Verbal Learning Test

    Measured: immediately after the intevention

  15. Rey Auditory Verbal Learning Test

    Measured: 3 months post-intervention

  16. Rey Auditory Verbal Learning Test

    Measured: 9 months post-intervention

Secondary outcomes (12)
  1. Clinical Dementia Rating Scale

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  2. Digit Symbol Substitution Test

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  3. Digit Span

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  4. Verbal Fluency Test

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  5. Geriatric Depression Scale

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  6. Neuropsychiatric Inventory

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  7. Recollection Task

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  8. N-Back

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  9. Rivermead Behavioral Memory Test

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  10. Instrumental Activities of Daily Living

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  11. Functional Capacities for Activities of Daily Living

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

  12. Multifactorial Memory Questionnaire

    Measured: baseline, immediately after the intervention, 3 months post intervention, and 9 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2010 (estimated)
  2. Study startOct 2010
  3. Primary completionJun 2014
  4. Study completionJun 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
63 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01212692
Sponsor's protocol ID
NA_00039100
Other IDs
R01AG034934
Status last verified
Dec 2015
First submitted
30 Sep 2010
Last updated
9 Dec 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing mentally stimulating activities in people with Mild Cognitive Impairment (MCI), run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-Ordered Pointing Task (time frame: baseline). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in